JW Pharma ApS: Financial statements 2024
CVR: 39330563
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
JW Pharma ApS (CVR 39330563) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -5,857 and a net result of DKK -5,857 compared with DKK -4,637 the year before. Equity in the 2024 report amounted to DKK -147,099.
- Gross Profit
- DKK -5,857
- Profit/Loss
- DKK -5,857
- Equity
- DKK -147,099
- Total Assets
- DKK 292,170
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | -6 t. | -6 t. | -147 t. | - |
| 2023 | - | -5 t. | -5 t. | -141 t. | - |
| 2022 | - | -8 t. | -9 t. | -137 t. | - |
| 2021 | - | -33 t. | -35 t. | -127 t. | - |
| 2020 | - | 70 t. | 69 t. | -92 t. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
JW Pharma ApS has published its annual report for 2023. Gross profit came to DKK -4,637, and the net result was DKK -4,637.
About JW Pharma ApS
JW Pharma ApS was a Danish company of the type Anpartsselskab based in København S, founded in 2018. The company has been dissolved on 27 October 2025. The company was registered under the industry Detailhandel med andre fødevarer. In 2024, the company reported a gross profit of DKK -5,857 and a net result of DKK -5,857 compared with DKK -4,637 the year before. Equity in the 2024 report amounted to DKK -147,099.